SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-018580
Filing Date
2021-03-08
Accepted
2021-03-08 16:48:30
Documents
2
Period of Report
2021-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1539
2 POA DOCUMENT poa.txt EX-24.3_971073 3020
  Complete submission text file 0001209191-21-018580.txt   6119
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRACON PHARMACEUTICALS, INC. 4350 LA JOLLA VILLAGE DRIVE, SUITE 800 SAN DIEGO CA 92122
Business Address
Johnson-Pratt Lisa (Reporting) CIK: 0001849760 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36818 | Film No.: 21722587